Correlation of imaging and plasma-based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC): A GOG 218 ancillary data analysis.

Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218

Gynecologic Oncology ◽

10.1016/j.ygyno.2019.07.020 ◽

2019 ◽

Vol 155 (1) ◽

pp. 69-74 ◽

Cited By ~ 1

Author(s):

K.N. Slaughter Wade ◽

M.F. Brady ◽

T. Thai ◽

Y. Wang ◽

B. Zheng ◽

...

Keyword(s):

Ovarian Cancer ◽

Data Analysis ◽

Gynecologic Oncology ◽

Prognostic Biomarkers ◽

Oncology Group ◽

Measurements of sarcopenia as predictive biomarkers for response to anti-angiogenic treatment in epithelial ovarian cancer: An NRG/GOG ancillary data analysis of GOG 218

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.03.237 ◽

2017 ◽

Vol 145 ◽

pp. 100-101

Author(s):

M.E. Buechel ◽

M.F. Brady ◽

Y. Wang ◽

S. Mirniaharikandehei ◽

H. Liu ◽

...

Keyword(s):

Ovarian Cancer ◽

Data Analysis ◽

Predictive Biomarkers ◽

Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: An ancillary data analysis of the NRG Oncology/Gynecologic Oncology Group (GOG-0218) study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.07.121 ◽

2017 ◽

Vol 147 (1) ◽

pp. 98-103 ◽

Cited By ~ 10

Author(s):

N.T. Phippen ◽

A.A. Secord ◽

S. Wolf ◽

G. Samsa ◽

B. Davidson ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Data Analysis ◽

Gynecologic Oncology ◽

Advanced Epithelial Ovarian Cancer

Oncology Group ◽

Ancillary Data ◽

Measurements of adiposity as predictive biomarkers for response to anti-angiogenic treatment in epithelial ovarian cancer: An NRG/GOG ancillary data analysis of GOG 218

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.03.086 ◽

2017 ◽

Vol 145 ◽

pp. 32-33

Author(s):

K.N. Slaughter ◽

M.F. Brady ◽

T. Thai ◽

Y. Wang ◽

B. Zheng ◽

...

Keyword(s):

Ovarian Cancer ◽

Data Analysis ◽

Predictive Biomarkers ◽

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study

Cancer ◽

10.1002/cncr.30414 ◽

2016 ◽

Vol 123 (6) ◽

pp. 985-993 ◽

Cited By ~ 10

Author(s):

Bunja J. Rungruang ◽

Austin Miller ◽

Thomas C. Krivak ◽

Neil S. Horowitz ◽

Noah Rodriguez ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Ancillary Data ◽

Stage Iiic

What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? A Gynecologic Oncology Group ancillary data study

Gynecologic Oncology ◽

10.1016/j.ygyno.2013.04.078 ◽

2013 ◽

Vol 130 (1) ◽

pp. e9

Author(s):

B. Rungruang ◽

A. Miller ◽

T. Krivak ◽

N. Horowitz ◽

N. Rodriguez ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Ancillary Data ◽

Stage Iiic

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial

Gynecologic Oncology ◽

10.1016/j.ygyno.2021.12.012 ◽

2021 ◽

Author(s):

Carol Aghajanian ◽

Elizabeth M. Swisher ◽

Aikou Okamoto ◽

Karina Dahl Steffensen ◽

Michael A. Bookman ◽

...

Keyword(s):

Ovarian Cancer ◽

Data Analysis ◽

Primary Treatment ◽

Serous Ovarian Cancer ◽

Dosing Regimen ◽

Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study

Gynecologic Oncology ◽

10.1016/j.ygyno.2017.11.018 ◽

2018 ◽

Vol 148 (2) ◽

pp. 275-280 ◽

Cited By ~ 14

Author(s):

C.A. Hamilton ◽

A. Miller ◽

Y. Casablanca ◽

N.S. Horowitz ◽

B. Rungruang ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Advanced Epithelial Ovarian Cancer

Oncology Group ◽

Ancillary Data ◽

Clinicopathologic Characteristics ◽

Term Survival ◽

Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2020.05.644 ◽

2020 ◽

Vol 159 ◽

pp. 346-347

Author(s):

W.Y. Hwang ◽

S.I. Kim ◽

M. Lee ◽

K. Kim ◽

J.H. No ◽

...

Keyword(s):

Ovarian Cancer ◽

Survival Outcome

Cyclin D1 overexpression and p53 mutation status in epithelial ovarian cancer

Journal of the Society for Gynecologic Investigation ◽

10.1016/s1071-5576(99)00002-7 ◽

1999 ◽

Vol 6 (2) ◽

pp. 102-108 ◽

Cited By ~ 6

Author(s):

K Shigemasa

Keyword(s):

Ovarian Cancer ◽

Cyclin D1 ◽

P53 Mutation ◽

Mutation Status